T. Ni

Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer

Haiming Dai, Wulin Yang, Hongzhi Wang, 2021, International journal of biological sciences.